PE20171082A1 - PROCESS TO INCREASE THE STABILITY OF A COMPOSITION INCLUDING POLYINSATURATED OMEGA-6 FATTY ACIDS - Google Patents

PROCESS TO INCREASE THE STABILITY OF A COMPOSITION INCLUDING POLYINSATURATED OMEGA-6 FATTY ACIDS

Info

Publication number
PE20171082A1
PE20171082A1 PE2017001086A PE2017001086A PE20171082A1 PE 20171082 A1 PE20171082 A1 PE 20171082A1 PE 2017001086 A PE2017001086 A PE 2017001086A PE 2017001086 A PE2017001086 A PE 2017001086A PE 20171082 A1 PE20171082 A1 PE 20171082A1
Authority
PE
Peru
Prior art keywords
composition
weight
omega
fatty acids
lysine
Prior art date
Application number
PE2017001086A
Other languages
Spanish (es)
Inventor
Gunter Knaup
Milan Latinovic
Michael Schwarm
Original Assignee
Evonik Degussa Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52344990&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20171082(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evonik Degussa Gmbh filed Critical Evonik Degussa Gmbh
Publication of PE20171082A1 publication Critical patent/PE20171082A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00Preserving by using additives, e.g. anti-oxidants
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00Preserving by using additives, e.g. anti-oxidants
    • C11B5/0021Preserving by using additives, e.g. anti-oxidants containing oxygen
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00Preserving by using additives, e.g. anti-oxidants
    • C11B5/0085Substances of natural origin of unknown constitution, f.i. plant extracts
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/18Lipids
    • A23V2250/186Fatty acids
    • A23V2250/1882Polyunsaturated fatty acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se refiere a un proceso para aumentar la estabilidad hacia la oxidacion de una composicion que comprende acidos grasos omega-6 poliinsaturados que comprende las siguientes etapas: (i) proporcionar una composicion de partida que comprende al menos un componente acido graso omega-6 poliinsaturado; (ii) proporcionar una composicion de lisina; (iii) mezclar soluciones acuosas, acuoso-alcoholicas o alcoholicas de composicion de partida y composicion de lisina, y someter posteriormente la mezcla resultante a condiciones de secado por pulverizacion, formando asi una composicion de producto solido que comprende al menos una sal de un cation derivado de lisina con un anion derivado a partir de un acido graso omega-6 poliinsaturado; la composicion del producto que presenta un contenido de disolvente SC seleccionado entre los siguientes: SC <5% en peso, SC <3% en peso, SC <1 %en peso, SC <0.5% en peso. Dichos compuestos obtenibles son utiles en el tratamiento de cancerIt refers to a process for increasing the oxidation stability of a composition comprising polyunsaturated omega-6 fatty acids comprising the following steps: (i) providing a starting composition comprising at least one polyunsaturated omega-6 fatty acid component; (ii) providing a lysine composition; (iii) mixing aqueous, aqueous-alcoholic or alcoholic solutions of the starting composition and lysine composition, and subsequently subjecting the resulting mixture to spray-drying conditions, thus forming a solid product composition comprising at least one salt of a cation derivative of lysine with an anion derived from a polyunsaturated omega-6 fatty acid; the composition of the product having a solvent content SC selected from the following: SC <5% by weight, SC <3% by weight, SC <1% by weight, SC <0.5% by weight. Said obtainable compounds are useful in the treatment of cancer

PE2017001086A 2014-12-23 2015-12-17 PROCESS TO INCREASE THE STABILITY OF A COMPOSITION INCLUDING POLYINSATURATED OMEGA-6 FATTY ACIDS PE20171082A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14199976 2014-12-23

Publications (1)

Publication Number Publication Date
PE20171082A1 true PE20171082A1 (en) 2017-08-03

Family

ID=52344990

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2017001086A PE20171082A1 (en) 2014-12-23 2015-12-17 PROCESS TO INCREASE THE STABILITY OF A COMPOSITION INCLUDING POLYINSATURATED OMEGA-6 FATTY ACIDS

Country Status (25)

Country Link
US (1) US20170367394A1 (en)
EP (1) EP3236783B1 (en)
JP (1) JP6714000B2 (en)
KR (1) KR20170094789A (en)
CN (1) CN107105693B (en)
AU (1) AU2015371457B2 (en)
BR (1) BR112017013445B1 (en)
CA (1) CA2969157C (en)
CL (1) CL2017001613A1 (en)
CO (1) CO2017005849A2 (en)
DK (1) DK3236783T3 (en)
ES (1) ES2776393T3 (en)
IL (1) IL252482B (en)
MX (1) MX2017008274A (en)
MY (1) MY190506A (en)
NZ (1) NZ732380A (en)
PE (1) PE20171082A1 (en)
PH (1) PH12017501144A1 (en)
PL (1) PL3236783T3 (en)
RU (1) RU2706072C2 (en)
SA (1) SA517381762B1 (en)
SG (1) SG11201704399RA (en)
TW (1) TWI693893B (en)
WO (1) WO2016102316A1 (en)
ZA (1) ZA201704821B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3072658C (en) 2017-08-15 2023-01-24 Evonik Operations Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
WO2019093708A1 (en) * 2017-11-08 2019-05-16 김승수 Method for producing odor-suppressing composition containing unsaturated oil and arginine
WO2021023857A1 (en) 2019-08-08 2021-02-11 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
TW202120076A (en) * 2019-08-08 2021-06-01 德商贏創運營有限公司 Down streaming process for the production of polyunsaturated fatty acid salts
EP4009960A1 (en) 2019-08-08 2022-06-15 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
EP4009959A1 (en) 2019-08-08 2022-06-15 Evonik Operations GmbH Method of preparing a solid dosage form and a lubricant
EP3804699A1 (en) 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
JP2023514505A (en) * 2020-01-30 2023-04-06 シリサイクル インコーポレイティド Method for preparing basic amino acid solid salt of polyunsaturated fatty acid
US20230037453A1 (en) 2020-04-01 2023-02-09 Evonik Operations Gmbh Preparation for use as vasorelaxant
EP4125438A1 (en) 2020-04-01 2023-02-08 Evonik Operations GmbH Preparation for use as antioxidant
CN111635306B (en) * 2020-06-12 2022-09-27 上海海益环保科技有限公司 Erucic acid composite stabilizer and method for preparing stable erucic acid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264987B1 (en) * 1993-12-14 1996-10-17 Prospa Bv SALTS OF A POLYUNSATURATED FATTY ACID AND PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM
AU2003284633B2 (en) * 2002-11-22 2008-07-10 Nippon Suisan Kaisha, Ltd. External composition containing polyunsaturated fatty acid or its salt or ester
WO2004112777A1 (en) * 2003-06-20 2004-12-29 Mochida Pharmaceutical Co., Ltd. Composition for prevention/treatment for varicose vein
CN101115404B (en) * 2005-02-02 2013-06-05 帝斯曼知识产权资产管理有限公司 Powder compositions
US20140199313A1 (en) * 2005-03-02 2014-07-17 Metanomics Gmbh Process for the Production of Fine Chemicals
NZ573327A (en) * 2006-06-05 2012-07-27 Ocean Nutrition Canada Ltd Microcapsules with improved shells
WO2008003064A2 (en) * 2006-06-29 2008-01-03 Martek Biosciences Corporation Sweetened oil compositions and methods of making
CN101909467B (en) * 2007-11-01 2013-04-24 恩兹默泰克有限公司 Lipid mixture for infant nutrition
WO2012002464A1 (en) * 2010-06-30 2012-01-05 持田製薬株式会社 ω3 FATTY ACID COMPOUND PREPARATION

Also Published As

Publication number Publication date
PH12017501144A1 (en) 2018-03-05
ZA201704821B (en) 2019-06-26
WO2016102316A1 (en) 2016-06-30
SG11201704399RA (en) 2017-07-28
JP6714000B2 (en) 2020-06-24
CO2017005849A2 (en) 2017-09-20
RU2017125963A (en) 2019-01-24
NZ732380A (en) 2024-03-22
TW201639463A (en) 2016-11-16
DK3236783T3 (en) 2020-04-27
ES2776393T3 (en) 2020-07-30
EP3236783A1 (en) 2017-11-01
CN107105693A (en) 2017-08-29
CA2969157A1 (en) 2016-06-30
CL2017001613A1 (en) 2018-01-12
AU2015371457A1 (en) 2017-06-22
IL252482A0 (en) 2017-07-31
CN107105693B (en) 2021-04-02
BR112017013445B1 (en) 2021-11-23
SA517381762B1 (en) 2020-10-27
KR20170094789A (en) 2017-08-21
MY190506A (en) 2022-04-26
EP3236783B1 (en) 2020-02-05
AU2015371457B2 (en) 2020-04-23
TWI693893B (en) 2020-05-21
RU2706072C2 (en) 2019-11-13
PL3236783T3 (en) 2020-06-15
RU2017125963A3 (en) 2019-06-18
CA2969157C (en) 2024-05-28
US20170367394A1 (en) 2017-12-28
MX2017008274A (en) 2017-10-02
BR112017013445A2 (en) 2018-06-26
JP2018501790A (en) 2018-01-25
IL252482B (en) 2021-08-31

Similar Documents

Publication Publication Date Title
PE20171083A1 (en) PROCESS TO INCREASE THE STABILITY OF A COMPOSITION INCLUDING POLYINSATURATED OMEGA-3 FATTY ACIDS
PE20171082A1 (en) PROCESS TO INCREASE THE STABILITY OF A COMPOSITION INCLUDING POLYINSATURATED OMEGA-6 FATTY ACIDS
CL2019002663A1 (en) Production of long-chain polyunsaturated fatty acids in plant cells. (divisional request 201702448)
WO2016122887A8 (en) Oligosaccharide compositions for use as animal feed and methods of producing thereof
BR112018009885A2 (en) production of fatty olefin derivatives by olefin metathesis
CU24410B1 (en) BENZIMIDAZOL-2-AMINAS AS MIDH1 INHIBITORS
AR097954A1 (en) TREATED FILLING MATERIAL, COMPOSITIONS CONTAINING IT AND PREPARED ITEMS FROM THE SAME
RU2015113638A (en) CRYSTALLINE SUBSTANCE AND PHARMACEUTICAL PRODUCT CONTAINING IT
NZ747847A (en) Lipid compositions
CO6590210A1 (en) Complex obtained from mixtures of hyaluronic acid or a salt thereof and chondroitin sulfate
BR112018013349A2 (en) adhesive composition, method of preparing an adhesive composition, and adhesive product
BR112017019749A2 (en) Two-step emulsification process for preparing infant formula
CL2016001375A1 (en) Composition, which comprises bioactive agent (immunogen) dispersed in oil droplets, enteric coating polymer, a mucoadhesive polymer, its method of preparation and use for oral administration of a bioactive agent.
AR100618A1 (en) PREPARATION PROCEDURE FOR HUMAN ALBUMIN WITH REDUCED DISSOLVED OXYGEN LEVEL
CL2015002376A1 (en) Acetylated wood fiber
AR097143A1 (en) MINERAL FOOD COMPOSITION FOR LAMER FOR RUMINANTS AND METHOD TO PREPARE IT
BR112016025931A8 (en) composition of extruded soap bar, bar and method for enhancing the transparency of soap bars
AR098035A1 (en) FOOD COMPOSITION FOR RUMINANT ANIMALS CONTAINING PROTEINS AND PREPARATION METHOD
AR095333A1 (en) NUTRITIONAL COMPOSITIONS CONTAINING A PEPTIDE COMPONENT AND METHOD TO REDUCE THE INCIDENCE OF AUTOIMUNE DISEASE
AR090554A1 (en) BENCEN-POLICARBOXILIC ACID COMPOUNDS
AR097148A1 (en) FOOD COMPOSITION FOR RUMINANTS AND METHOD TO PREPARE IT
AR097142A1 (en) LIQUID FOOD COMPOSITION FOR RUMINANTS AND METHODS TO PREPARE IT
RU2011150458A (en) METHOD FOR PREPARING FODDER PRODUCT
PH12014502817B1 (en) Compounds from the fruits of acrocomia crispa and acrocomia aculeata for use against oxidative stress and inflammation
AR097517A1 (en) ANTITRANSPIRING COMPOSITIONS WITH HYDROXIALQUILUREA